Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

984 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Newer opportunities in systemic therapy of lung cancer.
Rajan A, Gutierrez M, Giaccone G. Rajan A, et al. Among authors: giaccone g. Ann Oncol. 2008 Sep;19 Suppl 7(Suppl 7):vii31-7. doi: 10.1093/annonc/mdn445. Ann Oncol. 2008. PMID: 18790973 Free PMC article. No abstract available.
A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial.
Planting A, Helle P, Drings P, Dalesio O, Kirkpatrick A, McVie G, Giaccone G. Planting A, et al. Among authors: giaccone g. Ann Oncol. 1996 Feb;7(2):139-44. doi: 10.1093/oxfordjournals.annonc.a010540. Ann Oncol. 1996. PMID: 8777169 Free article. Clinical Trial.
Medical treatment of non-small-cell lung cancer.
Buter J, Giaccone G. Buter J, et al. Among authors: giaccone g. Ann Oncol. 2005;16 Suppl 2:ii229-32. doi: 10.1093/annonc/mdi721. Ann Oncol. 2005. PMID: 15958463 Free article. Review. No abstract available.
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials.
Bell DW, Lynch TJ, Haserlat SM, Harris PL, Okimoto RA, Brannigan BW, Sgroi DC, Muir B, Riemenschneider MJ, Iacona RB, Krebs AD, Johnson DH, Giaccone G, Herbst RS, Manegold C, Fukuoka M, Kris MG, Baselga J, Ochs JS, Haber DA. Bell DW, et al. Among authors: giaccone g. J Clin Oncol. 2005 Nov 1;23(31):8081-92. doi: 10.1200/JCO.2005.02.7078. Epub 2005 Oct 3. J Clin Oncol. 2005. PMID: 16204011 Clinical Trial.
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.
Efficace F, Bottomley A, Smit EF, Lianes P, Legrand C, Debruyne C, Schramel F, Smit HJ, Gaafar R, Biesma B, Manegold C, Coens C, Giaccone G, Van Meerbeeck J; EORTC Lung Cancer Group and Quality of Life Unit. Efficace F, et al. Among authors: giaccone g. Ann Oncol. 2006 Nov;17(11):1698-704. doi: 10.1093/annonc/mdl183. Epub 2006 Sep 12. Ann Oncol. 2006. PMID: 16968876 Free article. Clinical Trial.
Antiangiogenic therapy in nonsmall cell lung cancer.
Gutierrez M, Giaccone G. Gutierrez M, et al. Among authors: giaccone g. Curr Opin Oncol. 2008 Mar;20(2):176-82. doi: 10.1097/CCO.0b013e3282f4e55e. Curr Opin Oncol. 2008. PMID: 18300767 Review.
Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies.
Kummar S, Doroshow JH, Tomaszewski JE, Calvert AH, Lobbezoo M, Giaccone G; Task Force on Methodology for the Development of Innovative Cancer Therapies (MDICT). Kummar S, et al. Among authors: giaccone g. Eur J Cancer. 2009 Mar;45(5):741-6. doi: 10.1016/j.ejca.2008.10.024. Epub 2008 Dec 16. Eur J Cancer. 2009. PMID: 19091546 Free PMC article. Review.
984 results